
C4 Therapeutics, Inc.
CCCCNasdaqCIK 1662579HealthcareFiscal year ends Dec 31
Reports and events: 116 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-05-2016:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001564590-21-029081 |
| 2021-05-1316:38 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001564590-21-027606 |
| 2021-05-1316:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-21-027584 |
| 2021-04-3016:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001564590-21-022516 |
| 2021-04-2616:22 ET | DEF 14A | Proxy statementPeriod 2021-06-15 | 0001564590-21-020538 |
| 2021-03-1116:19 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001564590-21-012531 |
| 2021-03-1116:10 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001564590-21-012504 |
| 2021-01-1217:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-001015 |
| 2021-01-0616:49 ET | 8-K | 7.01 Regulation FD disclosure | 0001564590-21-000428 |
| 2020-11-1917:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-20-054669 |
| 2020-11-1216:28 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001564590-20-053604 |
| 2020-11-1216:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-291672 |
| 2020-10-1616:09 ET | SC 13D | Ownership report, active investor | 0001193125-20-271093 |
| 2020-10-0616:46 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-20-264807 |
| 2020-09-2806:07 ET | S-1/A | Registration statement, amended | 0001193125-20-255106 |
| 2020-09-1017:26 ET | S-1 | Registration statement | 0001193125-20-243234 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:39 ET. Listed shows no prices and gives no investment advice.